| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Blume-Jensen Peter is a President And CEO at ACRV. Recent filings cover 1 purchase and 3 sales. Those positions are worth an estimated $4.9M at current prices.
Blume-Jensen Peter's largest disclosed position is in ACRV as President And CEO, worth about $4.9M. Net of sales, the recent Form 4 record there shows accumulation of 33,251 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | ACRV Acrivon Therapeutics, Inc. | President And CEO | Sell | 14,036 | $2.21 | $30,969.03 | -0.6% | - | - | |
| Aug 18, 2026 | ACRV Acrivon Therapeutics, Inc. | President And CEO | Sell | 1,713 | $2.01 | $3,443.13 | - | - | - | |
| Jan 14, 2026 | ACRV Acrivon Therapeutics, Inc. | President And CEO | Buy | 49,000 | $1.68 | $82,124.00 | +2.4% | -14.8% | - |